Stocks/NATR

NATR

Nature's Sunshine Products, Inc.
Consumer Defensive·Packaged Foods
$21.28
$374M market cap
Claude Rating
6/10SLIGHT BUY
Revenue
$489.8M
Free Cash Flow
$23.0M
Rev Growth
+8.5%
FCF Margin
4.7%
P/FCF
16.3x
EV/FCF
13.4x
Fwd EV/EBITDA
6.6x
Fair Value
$25.50
Upside
+19.8%

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care prod

2-Year Price History

$21.85+45.3%
$12$14$16$18$20$22$24$26volJun 24Oct 24Jan 25May 25Sep 25Jan 26May 26

Quarterly Financials & Projections

Quarterly Waterfall ($ M)
PeriodRevEBITDAOpInNIOCFFCFCapExCashDebtSharesROICIntCovEV/EBITDA
Est2028-Q1136.014.7--7.1--1.4-2.5147.4----------
Est2027-Q4137.014.0--6.6--11.0-2.7146.1----------
Est2027-Q3140.014.7--7.4--15.4-2.1135.1----------
Est2027-Q2132.013.2--6.6--5.9-2.4119.7----------
Est2027-Q1129.012.3--5.8---0.7-2.3113.8----------
Est2026-Q4130.011.4--4.6--9.1-2.6114.4----------
Est2026-Q3133.012.2--5.3--14.0-2.0105.3----------
Est2026-Q2125.010.6--4.8--3.8-2.391.3----------
Act2026-Q1122.911.49.55.1-1.9-4.3-2.587.622.417.932.9%326.1x8.0x
Act2025-Q4123.88.85.34.19.97.6-2.393.918.917.924.5%326.7x4.8x
Act2025-Q3128.313.29.05.318.516.8-1.795.614.318.035.3%--4.6x
Act2025-Q2114.811.14.35.34.33.0-1.481.315.619.017.0%461.2x4.6x
Act2025-Q1113.310.66.24.82.61.5-1.186.514.918.923.3%506.1x5.5x
Act2024-Q4118.27.14.6-0.312.210.0-2.284.714.218.518.7%--5.4x
Act2024-Q3114.68.85.34.49.67.9-1.778.715.318.920.7%--5.9x
Act2024-Q2110.69.15.61.41.3-2.1-3.468.715.419.124.0%--9.3x
Act2024-Q1111.07.84.62.32.2-1.5-3.777.819.819.217.2%--7.5x
Act2023-Q4108.910.35.79.09.68.4-1.382.414.919.434.8%--7.9x
Act2023-Q3111.29.05.82.814.49.9-4.576.016.019.527.0%--7.0x
Act2023-Q2116.69.97.02.47.95.5-2.469.017.819.830.3%--5.4x
Act2023-Q1108.63.00.20.99.37.0-2.365.719.119.40.8%--4.4x
Act2022-Q4102.87.14.22.03.60.7-2.960.019.219.317.7%--4.4x
Act2022-Q3104.57.75.00.16.55.5-1.057.020.019.522.6%----
Act2022-Q2104.28.45.80.5-1.4-3.7-2.256.322.019.623.7%----
Act2022-Q1110.54.11.3-3.0-7.9-9.4-1.566.523.119.64.8%----
Historical Valuation

Multiples vs the company's own history — cheap or rich relative to itself? Historical fiscal years, then TTM, then forward projections (E). Forward rows hold today's price against projected earnings, so the multiple compresses if the company grows into it.

YearPriceRev GrEBITDA %EBITDAEV/EBITDAEV/FCFP/EP/S
20228.326.5%274.4×n/mn/m0.4×
202317.29+5.5%7.2%327.9×8.2×21.3×0.7×
202414.66+2.0%7.2%335.4×12.3×32.1×0.5×
202521.58+5.7%9.1%444.8×7.3×14.7×0.6×
TTM21.28+7.3%9.1%450.0×0.0×0.0×0.0×
2027E21.28+9.8%0.1%10.0×0.0×0.0×0.0×

EBITDA in reporting-currency $M. Historical multiples use year-end market cap (split-adjusted price history); TTM & forward years use today's.

AI Analysis

LLM Evaluations

Claude6/10SLIGHT BUYFV: $25.50

Nature's Sunshine is a well-run niche health supplement company executing a successful digital transformation that is driving record revenues and improving margins. The zero-debt balance sheet with $87.6M cash provides a strong floor, and the 4.1% dividend yield offers income support. However, the stock trades near fair value at ~18x trailing FCF, and the ambitious $1B revenue target requires significant execution over many years. The MLM business model carries inherent regulatory and reputational risks, and the Q1 2026 negative operating cash flow raises near-term earnings quality concerns. Digital/subscription growth is genuinely impressive but faces tougher comps ahead. The Fosun Pharma secondary offering creates supply overhang. At current levels, the risk/reward is modestly positive but not compelling enough for high conviction — the stock is fairly priced for mid-single-digit growth with gradual margin expansion.

Catalyst Continued digital subscription growth driving margin expansion above 10% EBITDA; successful entry into German market and pan-Asian product launches in H2 2026; potential accretive bolt-on acquisition using the substantial cash pile; resolution of Fosun Pharma overhang.
Risk The MLM business model faces structural headwinds from DTC wellness brands offering lower-priced alternatives, combined with increasing regulatory scrutiny of auto-renewal subscription programs that are central to NATR's growth strategy. A regulatory crackdown or consultant attrition could rapidly unwind recent gains.
Trend
IMPROVING
Mgmt
7/10
Quarter
7/10
Exp. Move
+3.0%

Latest Earnings Call

Transcript Summary

Nature's Sunshine Products (NSP) delivered record Q1 2026 results, with sales growing 9% to $122.9 million and EBITDA jumping 33% to $14.6 million. Growth was robust globally, highlighted by a 42% increase in North American digital sales and a significant turnaround in China driven by Autoship subscriptions. Gross margins expanded to 73.2% due to operational efficiencies and a higher digital sales mix. CEO Kenneth Romanzi introduced a 'Vision for Growth' aiming to double revenue to $1 billion and reach a 15% EBITDA margin. Key growth drivers include international expansion into Germany, technological investments led by a new CTO, and enhanced direct selling penetration in the U.S. and China. Management provided a transparent roadmap for long-term margin improvement, attributing gains to manufacturing scale and lower commissions in the digital channel. Despite a cautious outlook regarding the conflict in Iran and planned spending increases in Q2 and Q3, the company remains in a strong financial position with zero debt and $87.6 million in cash. NSP is well-positioned to leverage its digital momentum and product innovation to capture a larger share of the global supplements market while maintaining high profitability levels.

Valuation & Metrics

Market Stats

Price$21.28
Market Cap$374M
Enterprise Value$309M
P/S Ratio0.8x
P/FCF16.3x
EV/FCF13.4x
FCF Margin (TTM)4.7%
FCF Yield6.2%
Dividend Yield (TTM)4.7%
Annual Dilution-4.9%
CurrencyUSD

TTM Financial Snapshot

Revenue$489.8M
Net Income$19.9M
Free Cash Flow$23.0M

Revenue Growth (YoY)+8.5%
EBITDA Margin9.1%
Net Margin4.1%
FCF Margin4.7%
CapEx % of Revenue1.6%
SBC % of Revenue0.1%
ROIC27.4%
WC Change % Rev-1.0%
Interest Coverage517.6x

DCF Fair Value Estimate

$25.65
+20.5% upside
Fair Enterprise Value$395M
− Net Debt$-65M
= Fair Equity$460M
Revenue Growth5.4% → 4.0%
FCF Margin4.7% → 8.0%
Discount Rate13.0%
Terminal EV/FCF13.0x

Forward Outlook & Risk

Short Interest

Short % of Float1.6%
Short Shares0.3M
Days to Cover4.0
Change (vs Prior)+20.1%
Short % Float History
1.60%+1.20pp
0.4%0.6%0.8%1.0%1.2%1.4%1.6%04-3007-1509-1511-1401-1504-30

Options

Call IV (ATM)--
Put IV (ATM)42%
ATM Spread--
Call $OI (near money)$16K
Put $OI (near money)$4K
ATM ExpiryJuly 17, 2026 (56D)
ATM Strike$22.5
Major Expirations2
Near-money chain · July 17, 2026
StrikeCall Bid/AskCall OIPut Bid/AskPut OI
$12.50$7.50/$12.000--/$4.600
$15.00$5.00/$9.400--/$4.700
$17.50$2.50/$7.000--/$4.900
$20.00$2.25/$5.000--/$4.901
$22.50--/$1.401$1.35/$2.102
$25.00--/$5.000$0.80/$5.500
$30.00--/$0.950$5.50/$10.200
Snapshot: 2026-05-22

Forward Projections & Estimates

NTM Revenue Growth+5.6%
Forward FCF Margin5.1%
Forward EBITDA Margin9.0%
Forward P/FCF14.3x
Forward EV/FCF11.8x
Forward Int. Coverage--
Model Risk Score5/10
Bankruptcy Odds0%
Est. Borrow Rate5.0%
Terminal EV/FCF13.0x
LT Growth4.0%
LT FCF Margin8.0%

Employees

Headcount819
Revenue / Employee$598,032
Gross Profit / Employee$434,803
2022: 800 → 2023: 814 → 2024: 819 → 2025: 806 (0% CAGR)

Institutional Ownership

Headline & net flow

NET BUYING

In Q1 2026 so far (quarter still filing), institutions are net buyers — bought 10.6% of float, sold 2.7%.

Net flow · Q1 2026still filing
+7.8% of float (net)
Bought 10.6% · Sold 2.7%
150 filers reported (last quarter: 144)

Ownership composition

Active
72.0%(+32.7% YoY)
137 filers
hedge / family / endowment
Retail funds
Fidelity, Schwab, 401(k)
Passive
22.3%(+12.5% YoY)
9 filers
Vanguard, iShares, SPDR
Market makers
0.5%(+0.3% YoY)
5 filers
Citadel, Susquehanna
Insiders
20.1%
Form 4 — latest per insider
0%25%50%75%100%2022-062023-032023-122024-092025-062026-03
ActiveRetail fundsPassiveMarket makersRetail direct

Top holders

Fund$ valueCost basisΔ QoQΔ YoYα lifeFund AUM
WYNNEFIELD CAPITAL INC$59.3M$8.24+$0+$0-3.0%$148M
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.$42.8M$8.99+$0+$0-0.2%$993M
BlackRock, Inc.Passive$25.5M$14.45−$1.3M+$6.2M-0.2%$5.69T
DIMENSIONAL FUND ADVISORS LPPassive$21.5M$14.36−$27K+$405K-0.4%$480.92B
KENNEDY CAPITAL MANAGEMENT LLC$16.6M$14.66+$381K+$6.3M-1.5%$4.72B
ACADIAN ASSET MANAGEMENT LLC$15.8M$15.07+$642K+$4.4M-0.5%$70.48B
VANGUARD CAPITAL MANAGEMENT LLCPassive$14.3M$23.99+$14.3M+$14.3M$4.04T
AMERICAN CENTURY COMPANIES INC$13.8M$18.64+$2.9M+$6.5M+0.7%$193.48B
RENAISSANCE TECHNOLOGIES LLC$12.8M$16.52+$188K−$155K+1.2%$63.91B
GEODE CAPITAL MANAGEMENT, LLCPassive$8.9M$15.27+$288K+$2.0M+2.3%$1.61T
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.$8.2M$15.37+$0+$8.2M-0.3%$1.72B
STATE STREET CORPPassive$7.8M$16.60+$228K+$1.3M-0.2%$2.89T
Hillsdale Investment Management Inc.$7.6M$19.69+$2.3M+$7.6M+0.3%$3.68B
MORGAN STANLEY$6.4M$14.41−$1.4M+$1.5M-0.3%$1.65T
Boston Partners$5.3M$13.44+$231K+$5.3M+0.5%$95.40B
JACOBS LEVY EQUITY MANAGEMENT, INC$4.6M$19.31+$2.0M+$3.2M+0.4%$23.79B
JPMORGAN CHASE & CO$4.4M$14.85−$556K−$358K-0.2%$1.47T
SEI INVESTMENTS CO$4.3M$22.28+$1.9M+$4.0M-0.4%$108.06B
Nuveen, LLC$4.1M$17.36+$870K+$3.3M+0.0%$368.63B
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$4.1M$20.29+$3.0M+$4.1M+0.1%$184.72B
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.

Trading behavior

Smart-money alpha (lifetime, %/qtr)NEUTRAL
Holders
-0.46%
avg per quarter
Holders (ex-self)
-0.69%
excl. this stock
Buyers (this Q)
-0.03%
85 buyers · $0.07B in
Sellers (this Q)
-0.33%
40 sellers · $0.00B out
alpha coverage: 95% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
-22.1%
how holders react when this stock falls
On quiet Qs
-15.0%
−10% to +10% baseline
On rallies (+10%+)
-7.7%
how they react when this stock rises
Holders' portfolio flow this Q
-0.6%
outflows — trims may be forced
Sellers' portfolio flow this Q
+5.3%
Sellers grew AUM elsewhere — opinionated cut of this stock.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
-3.4%
Holder mid (any stock)
-2.9%
Holder rally (any stock)
-5.5%

Top Holders Over Time

5-year share-count history (top 10 holders by peak, incl. exited) + price

02.6M5.2M7.8M10.4M$8.24$12$16$20$242021-062022-062023-062024-062025-062026-03
hover the chart for per-quarter detailprice (right axis)
Fosun International LtdWYNNEFIELD CAPITAL INC2.5MPRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.1.8MPARADIGM CAPITAL MANAGEMENT INC/NYKENNEDY CAPITAL MANAGEMENT LLC691KACADIAN ASSET MANAGEMENT LLC658KAMERICAN CENTURY COMPANIES INC575KRENAISSANCE TECHNOLOGIES LLC532KWASATCH ADVISORS INCPUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.340K

Analyst Coverage

Analyst Coverage
Price Targets
Last Quarter (1 analysts)$37.007390.0%
Last Year (2 analysts)$29.003630.0%
Current Price$21.28
Analyst Ratings
2
2
Buy: 2Hold: 2Consensus: Buy
Consensus Estimates
QuarterRevenueEBITDANet IncEPSEPS Range# Analysts
2025 Q3120M10M3M$0.16$0.15 – $0.172
2025 Q4122M10M3M$0.18$0.16 – $0.212
2026 Q1122M10M4M$0.20$0.15 – $0.262
2026 Q2124M10M5M$0.27$0.27 – $0.271
2026 Q3132M11M6M$0.33$0.33 – $0.331
2026 Q4129M11M5M$0.28$0.28 – $0.281
2027 Q1126M10M6M$0.34$0.33 – $0.351
2027 Q2134M11M5M$0.28$0.28 – $0.281
2027 Q3135M11M6M$0.33$0.33 – $0.331
2027 Q4134M11M5M$0.27$0.27 – $0.271

Corporate

Executive Compensation (2023-2025)

Direct Pay$27.5M
Incentive & Other$9.4M
Total Compensation$36.9M
% of Revenue2.6%

Insider Trading (last 12mo)

Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Officers & directors
Buys ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Sells ($, 12mo)
$2.02M
12 txns · 4 insiders · 94,966 sh
Major holders (≥10% beneficial owners)
Buys ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Sells ($, 12mo)
$32.71M
1 txn · 1 insider · 2,854,607 sh
Recent transactions
DateSideInsiderTitleSharesPriceDollarsOwned $
2026-05-21SELLBrower Nathan Gofficer: EVP, General Counsel12,015$21.84$262K$949K
2026-03-13SELLLanoy Jonathan Davidofficer: SVP, Chief Accounting Officer4,000$24.70$99K$1.15M
2026-03-13SELLNorman Daniel Cofficer: EVP & President, Asia15,383$24.52$377K$1.37M
2026-03-13SELLYates Bryant Jofficer: EVP & President, Europe19,516$24.35$475K$2.07M
2025-12-12SELLYates Bryant Jofficer: EVP & President, Europe1,700$22.29$38K$2.20M
2025-11-18SELLLanoy Jonathan Davidofficer: SVP, Chief Accounting Officer5,000$20.45$102K$945K
2025-11-14SELLBrower Nathan Gofficer: EVP, General Counsel3,800$20.81$79K$973K
2025-11-12SELLNorman Daniel Cofficer: EVP & President, Asia8,884$20.46$182K$1.36M
2025-08-29SELLYates Bryant Jofficer: EVP & President, Europe4,672$16.71$78K$1.63M
2025-08-26SELLYates Bryant Jofficer: EVP & President, Europe5,000$16.77$84K$1.71M
2025-08-13SELLBrower Nathan Gofficer: EVP, General Counsel9,996$16.54$165K$799K
2025-08-13SELLLanoy Jonathan Davidofficer: SVP, Chief Accounting Officer5,000$16.51$83K$826K
2025-06-27SELLShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner2,854,607$11.46$32.71M$0

Order Flow (FINRA, ~3w lag)

18.3%retail+2.4pp
22.9%dark-2.6pp
week of 2026-04-13
10%20%30%40%50%24-1125-0225-0525-0825-1126-0226-04retail (non-ATS)dark (ATS)
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.

Revenue Breakdown

Revenue Segments

By Product (2026-Q1)
Personal Care Products$7.0M+53%
By Geography (2026-Q1)
All Other$47.6MNEW
UNITED STATES$35.6M+10%
TAIWAN$15.0M-16%
JAPAN$12.4MNEW
KOREA, REPUBLIC OF$12.2M+13%

Filing Risk Analysis

Filing Risk Scores

Nature’s Sunshine Products: Strong Balance Sheet Liquidity vs. Divergent Cash Conversion and MLM Legal Risk

Overall Risk
5/10
Fraud
3/10
Dilution
4/10
Insolvency
2/10
Earnings Overstated
7/10
Hidden Liabilities
5/10
Legal
6/10
Audit Warnings
2/10
Hidden Upside
4/10
Contextually Acceptable
7/10

Counter-Thesis

Counter-Thesis & Recent News

📰 Recent News

While NATR reported a revenue beat in Q1 2026 (May 2026), the print was 'mixed' as operating cash flow turned negative at -$1.8 million compared to +$2.6 million in the prior year (Source: Quiver Quantitative). Additionally, the company is facing rising SG&A expenses and management cautioned that the Ukraine conflict could impact demand and costs in 2026 (Source: Investing.com). A secondary public offering by major shareholder Fosun Pharma USA was also recently highlighted as a potential headwind for share price (Source: Nasdaq).

🐻 Bear Case

The bear case centers on the 'tepid' long-term revenue growth (approx. 5% CAGR) and the inherent instability of the Multi-Level Marketing (MLM) business model. Critics argue that NATR's high gross margins (73%+) are artificially inflated by the need to pay out 30.7% of sales as 'sales incentives' to consultants, making the products fundamentally overpriced compared to traditional retail. Skeptics believe the recent 'growth spurt' is a one-off reversal of timing in the Asia-Pacific region and shouldn't be extrapolated (Source: Seeking Alpha, Barchart).

🚩 Red Flags

A major red flag is the negative operating cash flow reported in May 2026, which occurred despite beating earnings estimates, suggesting 'accounting profits' are not translating into actual cash (Source: StockStory). Furthermore, there is significant insider overhang with Fosun Pharma seeking to exit its position via secondary offerings. The company's heavy reliance on the Asia market (a major portion of revenue) faces 'tough comparisons' in upcoming quarters, increasing the risk of a growth miss (Source: Public.com).

⚔️ Competitive Threats

NATR faces intense competition from direct-to-consumer (DTC) wellness brands that utilize social media marketing rather than expensive MLM tiers. These 'traditional' competitors can offer equivalent supplements at significantly lower price points because they lack NATR’s burden of paying out heavy commissions to multiple levels of independent distributors (Source: Seeking Alpha).

💬 Customer Sentiment

Sentiment is increasingly cautious regarding the 'MLM value proposition.' There is a growing consumer trend toward transparency and 'no-frills' pricing in the health supplement industry. Additionally, regulatory shifts in 2026 are increasingly targeting the design of 'subscription and auto-renewal programs,' which are central to NATR's current digital strategy, potentially leading to increased friction or legal challenges (Source: Arnold & Porter).

Full Earnings Call Transcript

Full Earnings Call Transcript — Q1 • 2026-05-07

Operator: Good afternoon, everyone. And thank you for participating in today's conference call to discuss Nature's Sunshine Products, Inc.'s financial results for the first quarter ended March 31, 2026. Joining us today are Nature's Sunshine Products, Inc. CEO, Kenneth Romanzi, CFO, L. Shane Jones, and General Counsel, Nathan G. Brower. Following their remarks, we will open up the call for analyst questions. Before we go further, I would like to turn the call over to Mr. Brower as he reads the company's safe harbor statement within the meaning of the Private Securities Litigation Reform Act of 1995 that provides important cautions regarding forward-looking statements. Nathan, please go ahead.
Nathan G. Brower: Thank you, Marissa. Good afternoon, and thanks for joining our conference call to discuss our first quarter 2026 financial results. I would like to remind everyone that this call is available for replay via telephonic dial-in through May 21, and via a live webcast that will be posted in the Investor Relations portion of our website at ir.naturesunshine.com. The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause the results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, our earnings release issued today, and other reports filed with the Securities and Exchange Commission. The information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein. Now I would like to turn the call over to the CEO of Nature's Sunshine Products, Inc., Kenneth Romanzi. Ken?
Kenneth Romanzi: Thank you, Lee. Good afternoon, everyone. Thank you for joining our first quarter earnings call. I am very pleased to report we delivered a very strong first quarter, growing sales 9% and EBITDA 33%, reflecting continued momentum across our key strategic initiatives. We generated sales growth across all regions, led by North America with over 9% constant currency growth, driven by our digital channel strategy, with strong engagement from both new and returning customers. A healthy increase in our active consultants across the globe also drove solid growth. Our first quarter performance underscores our focus on disciplined execution, strengthening consultant and customer acquisition, expanding our digital capabilities, accelerating adoption of our Autoship subscription programs, and improving gross margin. As we look ahead, we are confident that the key strategies of our vision for growth will drive accelerated sustainable growth and long-term shareholder value. I will update you on the progress we have made in developing our vision for growth a bit later in the call, after our CFO, L. Shane Jones, provides the details of our strong Q1 performance. Shane?
L. Shane Jones: Thank you, Ken. We are very pleased to report another outstanding quarter, with growth in constant currency terms across all our business units: North America, Asia, Europe, and Latin America. This growth continues to be bolstered by our expansion into new digital channels, strong adoption of our subscription Autoship programs, exceptional new customer acquisition, and strong partnerships with our independent consultants across the globe. Our efforts to modernize the business, expand digital capabilities, and strengthen engagement with both our customers and our independent consultants continue to drive momentum in the business. Now diving into specific financial performance. Net sales in the first quarter were $122.9 million, representing our strongest first quarter in company history and our third largest quarter ever. This represents a 9% increase versus the year-ago quarter, or a 7% increase excluding the impact of foreign exchange rates. Growth was driven by continued acceleration in North America, combined with strength in Asia Pacific and Europe. We continue to closely monitor the geopolitical tensions in Iran given the expected impact on inflation and potential short-term impact on consumer buying patterns. However, as of yet, consumer demand remains strong, as reflected in the robust sales growth that we are seeing. Looking at our results in more detail, starting with regional performance. In North America, we are building strong momentum, driven by rapid growth in digital while maintaining our core business across specialty retailers, practitioners, affiliates, and independent consultants. Q1 sales grew 9% year over year to $38.3 million, our best growth in over five years. Our digital business continues to produce very robust year-over-year growth, increasing 42% in Q1. This was fueled by continued strength in customer acquisition, coupled with robust adoption of our subscription Autoship program, leading to better retention and frequency from returning customers. Similar to the exceptionally strong growth that we have seen over the last several quarters, new digital customers increased 60% in Q1. Likewise, subscription Autoship continued to perform very well in Q1, accounting for 48% of the digital sales coming through our website. As we have highlighted before, continued improvement in this metric is a leading indicator for future growth and profitability, since the lifetime value of customers that utilize subscription Autoship is more than three times higher than other customers. We are also very excited about the growth of our social commerce business within digital. While still relatively small, in Q1 this business grew triple digits year over year. Also, while subscription Autoship in this channel just launched in the second half of last year, it already makes up 23% of total social commerce revenue. We are excited to see the fundamentals of this business continue to move in the right direction, validating the strategic investments we are making and strengthening our confidence that we will meet and exceed the goals we have set. As we have said many times, digital momentum is a key component of our broader transformation and represents an important long-term growth lever for our business. Given the very strong momentum in digital, we expect continued mid- to high-single-digit revenue growth in North America throughout 2026. Moving to our business in Asia Pacific, sales grew 7% year over year to $52.2 million, or 6% growth on a constant currency basis. This performance was driven by outstanding execution in China, Japan, and Korea, where sales increased [inaudible], 16%, and 14%, respectively, excluding the impact of foreign exchange. As outlined in our late last earnings call, the turnaround in China has been driven by very strong adoption of our subscription Autoship program, which has grown from nothing at this time last year to more than 25% of total revenue today, combined with a double-digit increase in independent consultants. During Q1, these fundamental drivers were combined with a strong response to our field activation efforts, yielding exceptional results. While we continue to be encouraged regarding the fundamentals of the China business, the 40% growth seen in Q1 is unlikely to be repeated in the coming quarter. The double-digit growth seen in Japan and Korea during Q1 came as a result of a very successful launch of our Lemara skincare products, along with strong year-over-year increases of independent consultants. We are very pleased with the commitment and strong execution from our independent consultants in these markets and believe that our focused, differentiated products along with our knowledgeable, passionate consultants position us well for continued growth in the APAC region. We are also pleased with the continued strength in our European business, where Q1 sales increased 9% versus the prior year to $26.4 billion, or 6% growth on a constant currency basis. These outstanding results were driven by 11% growth in Eastern Europe in local currency terms. The strength in Eastern Europe has been fueled by improved product availability as we have worked to ensure appropriate in-stock levels for our key products where we see high demand. This improvement was combined with outstanding execution from our independent consultants and some economic stabilization in the region. This remarkable growth is a testament to the perseverance and commitment of our staff in that area, given the continued war in the region. For the remainder of 2026, we expect continued mid-single-digit growth in Europe. Now turning to gross margin. We continue to build on the progress we have made over the past several quarters, as gross margin increased 116 basis points to 73.2% compared to 72.1% a year ago. This improvement represents the benefit of our ongoing gross margin initiatives and favorable market mix. These initiatives include renegotiating logistics contracts, better conversion costs to improve manufacturing efficiency, improved sourcing, more disciplined pricing, and other cost-saving measures. Despite some uncertainty regarding the short-term impact of the situation in Iran on inflation, we still anticipate continued modest improvement in gross margin. Therefore, during 2026, gross margins are likely to average around 73%, which represents a significant step up from where we have been historically. Volume incentives as a percentage of net sales were 30% compared to 30.8% in the year-ago quarter. The decrease was primarily due to the strong growth in our digital business as well as changes in market mix. Selling, general, and administrative expenses during the first quarter were $43.5 million compared to $40.6 million in the year-ago quarter. As a percentage of net sales, SG&A expenses were 35.4% for the first quarter compared to 35.8% a year ago. The $3 million increase versus prior year was primarily related to variable costs associated with the sales increase and compensation costs. While Q1 spend was less than the quarterly SG&A range communicated last quarter due to the timing of certain strategic investments, we expect quarterly SG&A of $45 million to $47 million for the remainder of the year as we ramp up these initiatives. Operating income increased 53% to $9.5 million, or 7.8% of net sales, compared to $6.2 million, or 5.4% of net sales in the year-ago quarter. GAAP net income attributable to common shareholders for the first quarter was $5.1 million, or $0.28 per diluted common share, compared to $4.7 million, or $0.25 per diluted common share in the year-ago quarter. Adjusted EBITDA, as defined in our earnings release, increased 33% to $14.6 million compared to $11 million in the year-ago quarter. The increase was primarily driven by the growth in sales and improvement in gross margin. Our balance sheet remains clean with cash and cash equivalents of $87.6 million and zero debt. Inventory decreased to $67.1 million at the end of the first quarter, a $1.2 million decrease versus Q4 last year. We expect to see a moderate increase in inventory during 2026 to ensure appropriate in-stock levels and fulfill continued strong demand. Net cash used by operating activities was $1.8 million compared to cash provided of $2.6 million in the prior-year period. We repurchased 20 thousand shares for approximately $500 thousand, or $24.54 per share, during the first quarter ended March 31, 2026, with $16.9 million remaining on our share repurchase program. Looking beyond share repurchases, our healthy capital allocation structure positions us well to continue our digital transformation and other strategic initiatives. Now turning to our 2026 outlook. We are reiterating the guidance issued last quarter, expecting full-year 2026 net sales to range between $500 million and $515 million, compared to $480 million for 2025. This equates to year-over-year growth of 4% to 7%. For adjusted EBITDA, we are guiding to a range of $50 million to $54 million, representing year-over-year growth of up to 19%. This incorporates a cautious stance regarding the potential impact of the Iran conflict on both demand and cost. Also, as communicated previously, this guidance includes measured investments to improve our technology infrastructure, drive further customer acquisition, advance geographic expansion, expand penetration in existing markets, and accelerate product innovation. These investments will ramp in Q2 and Q3 of this year, thereby temporarily reducing the double-digit EBITDA growth rate seen historically and in Q1 2026. We continue to see strong momentum in the business and believe that now is the time to make these key investments in order to position the company for sustained rapid growth in 2027 and beyond. Overall, we believe the business is well positioned to capitalize on current opportunities in a growing market and remain very optimistic about our ability to continue to unlock the substantial growth prospects that we see. Strategic initiatives we have been implementing are working, and we are confident in our ability to continue to accelerate growth in sales, profitability, and free cash flow. Now I will turn it back to Ken for some further commentary.
Kenneth Romanzi: Thank you, Shane. Well done. As I reviewed on our earnings call last quarter, Nature's Sunshine Products, Inc. has a very strong foundation driving today's results and one upon which we can build an accelerated vision for growth. The key pillars of this foundation include two very strong brands steeped in heritage and quality, Nature's Sunshine Products, Inc. and Synergy, operating in the large, global, and rapidly growing category of natural health supplements; a globally diverse business operating in over 40 countries around the world; exceptional product development capabilities sourcing and blending hundreds of nature's best ingredients from around the world and scientifically verifying their effectiveness; an army of independent consultants passionately representing our products every day around the world; a rapidly growing digital business penetrating new channels driven by a subscription model that enables consistent recurring revenue streams; a rock-solid balance sheet, with nearly $100 million in cash and no debt; and last but not least, a passionate mission-driven organization dedicated to elevating people's lives globally through improving their health and economic well-being, while delivering industry-leading results for our shareholders. To build upon this foundation, we have developed what we call Nature's Sunshine Products, Inc.'s Vision for Growth, with the goals of doubling our sales to $1 billion and to leverage our infrastructure to achieve a 15% EBITDA margin over time. Key elements of our vision for growth plan include: one, continued rapid expansion of our digital business; two, explore distribution in select U.S. brick-and-mortar retail channels, working in a complementary, harmonious manner with our existing business; three, deeper penetration in our direct selling markets. The U.S. and China, the world's largest consumer markets, are two markets where we see terrific opportunities. For example, our Asian brand Synergy is very small in the U.S. but rapidly growing, so we are doubling down to expand U.S. Synergy distribution as a key growth driver; four, expansion into new high-value markets. This year, we will enter Germany, our largest new market that we have entered since China in 2016, and the largest supplement market in Europe. Looking ahead, we plan to expand to attractive new Asian markets utilizing our very powerful Synergy Asia sales system; five, we will drive growth through sharper brand positioning and product innovation behind both the Nature's Sunshine Products, Inc. and Synergy brands. Our new product pipeline is very strong over the next two years, and we will share the details of these new product launches as their launch dates draw near; six, leveraging our supply chain for scale efficiency. With excess capacity in our manufacturing facility, we can drive higher variable margins with volume growth. In addition, we will be investing in automation to drive further efficiencies; and lastly, seven, with nearly $100 million in cash and a debt-free balance sheet, we are well positioned to pursue bolt-on accretive acquisitions and to leverage efficiencies in our manufacturing plant. By executing this vision for growth, we believe $1 billion in sales is within our grasp. We believe the sun has never shined brighter for Nature's Sunshine Products, Inc., and I look forward to sharing more about our vision for growth in the near future. Thank you for your time today and your continued support of Nature's Sunshine Products, Inc. I would now like to turn the call back to the operator for questions. Operator? Thank you.
Operator: Thank you, sir. Ladies and gentlemen, we will now begin the question and answer session. Should you have a question, please press star followed by one on your touchtone phone. You will hear a prompt that your hand has been raised. Should you wish to remove your hand from the queue, please press star followed by two. If you are using a speakerphone, please lift the handset before pressing any keys. Just a moment for your first question. And your first question comes from Susan Anderson with Canaccord Genuity.
Susan Kay Anderson: Nice to see another really strong quarter. Maybe if you can talk about the 15% EBITDA margin longer term. I am just curious if you could give us an idea of the building blocks to get there. How much is driven by gross margin expansion versus SG&A leverage? Or should we think about it as being equal between the two? Thanks.
Kenneth Romanzi: I will let Shane—Susan, great to hear your voice, and hopefully we will catch up soon personally. I will give you a general answer, and then Shane has a very laddered approach to how we are going to do this. It is really through scale. If we get the volume growth accelerated and we have good cost discipline, we can get the scale, and it comes in several areas. It is not just one big idea. It comes in several areas up and down the P&L.
L. Shane Jones: Okay, great. To get a little more specific for you, we are basically today a little over 10%. As we look at what we need to do to get there, there are three blocks. About one point of that is going to be coming from gross margin. That is continuing to do what we are doing, as well as, as Ken talked about, the scale portion as we put more volume through our manufacturing plant. We are underutilized today, so we will be able to be more efficient and drive efficiencies there. So that is about one point. About two points of that is through our volume incentives line. As you can see, we have brought that down significantly over the last year, and really the biggest push of what is making that happen is our digital business, where we do not pay commissions or do not pay as much commission as we do in other parts of our business. As we mix more to digital, that will continue to come down. So that is about two points. And then the final piece is just leveraging our SG&A as we continue to grow. That is also another two points. As we talk about it, that is not reducing headcount or anything like that. It is really just leveraging as we grow. It is a one, two, and two.
Susan Kay Anderson: Perfect. That is really helpful. And then maybe I saw you appointed a new chief technology officer. Digital has obviously been very strong and very successful, particularly in the U.S. Does this signal that you are going to continue to focus in that area and maybe even continue to expand the product offered on the DTC site as you see a lot more opportunity there longer term?
Kenneth Romanzi: Yes. The hiring of a CTO is crucially important. We have a really good IT group here. However, technology, as you know, in every business is a game changer these days, everywhere from your base infrastructure all the way to the use of AI. We needed a leader that came from very different experiences in industry, both for evolving our base ERP system as a company—we face some end-of-life dates in five or six years on our Oracle ERP system, so we have to figure out what is the next step there in our ERP system—to absolutely putting the pedal to the metal on digital growth. There is so much more we can do there and in the use of AI, as well as how we digitally enable our independent consultants. For instance, we just launched an app that allows independent consultants to do their entire business by phone, and there is so much more we can be doing with that. We just launched it, but there is so much more we can be doing. And John Hanasek, our new CTO, has a lot of experience in doing things like that. We are really taking technology and driving it across base infrastructure, digital growth, direct to consumer, as well as how we digitally enable the tens of thousands of independent consultants we have around the world. A lot of our investments this year, as we talked about regarding why we are not continuing the most recent double-digit EBITDA growth and only doing single-digit EBITDA growth this year, are because we are making enhanced investments. A lot of it is in technology.
Susan Kay Anderson: Okay, great. And then last question, if you could just give some color on the brands and products that drove this strong growth in each region, and how you are thinking about new products. Do you expect to roll out new products to each of the regions this year? Thanks.
Kenneth Romanzi: I do not want to get specific about new products too much in advance. We will let you know as they occur. But when you think about what brands drove the growth, Nature's Sunshine Products, Inc. is our brand in the U.S., in North America, Latin America, Europe, and in China. And then the rest of the Asia Pacific region—Korea, Taiwan, Japan, Southeast Asia—that is Synergy. So when we say APAC growth, it is both brands, because Nature's Sunshine Products, Inc. is in China and the rest of Asia has Synergy. Hopefully, that will give you a little bit of indication as to what brands are driving the growth. Both brands drove great growth in this quarter and continue to do so over time. Regarding new products, there is a smattering. We do not do the same new product everywhere. They are all on different time frames. We do have a very promising product that we are launching for the first time ever as a pan-Asian launch, meaning our three biggest Asian countries—Korea, Japan, and Taiwan—are all going to be launching the same product, the same formulation, at the same time through our very powerful Asia sales system. It has never been done before, so they are gearing up for that. As we get closer to the date, we will say what that product actually is. It is a way to leverage the power of that system unlike we have ever done before.
Susan Kay Anderson: Okay. Excited to see what that is. Thank you so much for all the details.
Operator: Thank you. At this time, this concludes our question and answer session. I would now like to turn the call back over to Mr. Romanzi for closing remarks.
Kenneth Romanzi: Thank you, Marissa. We would like to thank everybody for listening to today's call, and we look forward to speaking with you when we report on our second quarter 2026 results. Have a great night.
Operator: Ladies and gentlemen, this does conclude today's teleconference. You may disconnect your lines at this time. Thank you for your participation.